Goal 3 Good health and well-being
Iconovo develops generic inhaler products that makes high-quality treatments available at a lower cost for people that have limited resources to spend on medicine. Furthermore, Iconovo aims to replace injections with inhaled products that will make it easier to distribute essential medicine in warm climate and avoiding hazardous waste like used needles.
We strive to improve maternal health according to Objective 3. 1 in our project with Monash University where we develop oxytocin in ICOone to reduce mortality during childbirth due to excessive bleeding. We also work with ISR to develop an inhaled COVID-19 vaccine that can be distributed at room temperature and given without syringes by healthcare workers.
Goal 8 Decent work and economic growth
Through our global reach, we can work to ensure that our partners, customers, and suppliers have a good working environment for their employees and promote sustainable economic development. We will continuously develop our operations in Sweden and place high demands on the work environment.
Goal 13 Climate action
We review the amount of material in different processes and work to ensure that more medical plastic parts can be manufactured in environmentally friendly plastics. In the climate field, we can all help reduce emissions. For example, we are working on a digital transformation that results in us being able to make fewer trips while maintaining or even increasing efficiency.